No therapeutic, prophylactic, or diagnostic application is claimed or implied, and the peptide is not approved for human or veterinary use in Australia
They operate through fundamentally different biological pathways, which is why comparing them purely on "wrinkle outcomes" misses most of the picture
Pain Physician 2012
Staying informed, monitoring your health, and seeking timely medical advice are key steps
This leads to researchers using solutions well beyond their safe shelf life, with degraded potency they cannot detect visually
That CagriSema is approved, or approvable, anywhere as of mid-2026 it is investigational, with its benefitrisk profile still under regulatory review